Metachronous infiltration of bone marrow due to breast cancer and multiple myeloma

Year 2018, Volume: 4 Issue: 2, 136 - 139, 04.04.2018

Ahmet Peker , Hakan Yarkıcı , Mehmet Can Uğur , Harun Akar , Cengiz Ceylan , Dudu Solakoğlu Kahraman

https://doi.org/10.18621/eurj.341763

Cited By: 1

Abstract

Multiple primary tumors are rarely seen in clinical
practice. Cases of metastatic breast cancer associated with multiple myeloma
were rare in the literature. It is believed that simultaneously observed bone
marrow involvement due to breast cancer and multiple myeloma is sporadic. We
present a 49-year-old female patient with metastatic breast cancer who developed
multiple myeloma during breast cancer treatment. 

Keywords

Bone marrow involvement, breast cancer, multiple myeloma, metachronous malignancy

References

• [1] Rajkumar SV. Multiple myelomas: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011;8:57-65.
• [2] Kalender ME, Sevinç A, Tutar E, Camcı C. [Synchronous renal cell carcinoma with medullary carcinoma of the breast]. Türk Hematoloji-Onkoloji Dergisi 2005;2:90-93. [Article in Turkish]
• [3] Sarma M, Borde C, Subramanyam P, Shanmuga Sundaram P. Random synchronous malignancy in the male breast: a case report. J Breast Cancer 2013;16:442-6.
• [4] Jiao F, Yao LJ, Zhou J, Hu H, Wang LW. Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese patients. Asian Pac J Cancer Prev 2014;15:331-4.
• [5] Pastore AL, Palleschi G, Autieri D, Leto A, Ripoli A, Maggioni C, et al. Synchronous primary neoplasms of the bladder, skin and breast in a male patient: a case report. World J Surg Oncol 2013;11:282.
• [6] Uğur MC, Ekinci F, Soyaltın UE, Özkan F, Atasoy I, Ceylan C, et al. [Waldenstrom case developed secondary to chemotherapy]. Tepecik Eğit Hast Derg 2014;24:131-3. [Article in Turkish]
• [7] Eisinger F, Aubert L, Zanlucca S, Setz JF, Monges G, Sobol H, et al. [Synchronous cancers. A case with three localizations: rectal cancer associated with familial polyposis, breast cancer and adrenal gland cancer]. Presse Med 1995:24:1446. [Article in French]
• [8] Kılçıksız SÇ, Kaynak C, Eşki E, Yersal Ö, Ünlü İ, Çallı A, et al. [Evaluation of multiple primary tumors and single tumors charecteristics: a study from hospital-based cancer registry in İzmir]. Türk Onkoloji Dergisi 2007:22:55-62. [Article in Turkish]
• [9] Buiatti E, Crocetti E, Acciai S, Gafa L, Falcini F, Milandri C, et al. Incidence of second primary cancers in three Italian population-based cancer registries. Eur J Cancer 1997:33:1829-34.
• [10] Stegman R, Alexanian R. Solid tumors in multiple myeloma. Ann Intern Med 1979;90:780-2.
• [11] Sakai A, Kawano M, Kuramoto A. Interleukin-6 produced by renal-cell carcinoma cells and progression of multiple myeloma. N Engl J Med 1991;324:1893-4.
• [12] Kherfani A, Amri K, Hachem M, Abid L, Bouaziz M, Mestiri M. An association of vertebral breast cancer metastasis and multiple myeloma, revealed by a spinal cord compression. Pan Afr Med J 2014;19:168.
• [13] Sehgal T, Sharma S, Naseem S, Varma N, Das A, Sharma SC. Synchronous occurrence of prostate carcinoma and multiple myeloma: a case report. Indian J Hematol Blood Transfus 2014;30(Suppl 1):359-62.
• [14] Demir C, Atmaca M, Tasdemir E, Efe S. Association of multiple myeloma and gastric adenocarcinoma. J Clin Exp Invest 2011;2:110-3.